University Clinical Centre of Serbia

Belgrade 11030

3 studies enrolling now · 10 studies all time

What they study most

Acute Heart Failure With Reduced Ejection Fraction, Community-acquired Pneumonia, Influenza, COVID-19, Coronary Artery Disease, Dilated Cardiomyopathy, Heart Failure With Reduced Ejection Fraction (HFrEF), Moderate Hemophilia A, Multiple Sclerosis (MS) Primary Progressive, Neutropenia, Pneumonia, Bacterial, Pulmonary Artery Hypertension, Severe Hemophilia A, Solid Tumors

Studies at this site

• A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis — Recruiting now
• A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections — Recruiting now
• ANDREAS Registry (Assessment of Novel Drug-coated Balloon Revascularization: Effectiveness, Angiographic Outcomes, and Safety) — Recruiting now
• Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia — Recruiting now
• A Study to Evaluate Overall Health, Physical Activity, and Joint Outcomes in Participants With Severe or Moderate Hemophilia A Without Factor VIII Inhibitors on Emicizumab Prophylaxis — Running, not enrolling
• Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study — Paused
• Screening Study for Participants With Malignant Tumors — Completed
• Blinded Efficacy and Safety Study of CAL02 IV Plus SOC in Subjects With Severe Community-Acquired Bacterial Pneumonia — Running, not enrolling
• A Study to Assess the Hemodynamic Effects, Safety, Tolerability, and Pharmacokinetics of Intravenous APD418 in Adult Participants With Heart Failure With Reduced Ejection Fraction — Stopped early
• GB002 in Adult Subjects With Pulmonary Arterial Hypertension (PAH) — Completed